X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
daclatasvir (721) 721
index medicus (599) 599
hepatitis c (487) 487
humans (474) 474
hepatitis c virus (473) 473
ribavirin (400) 400
sofosbuvir (369) 369
gastroenterology & hepatology (322) 322
hepatitis c, chronic - drug therapy (294) 294
antiviral agents - therapeutic use (285) 285
hepatitis (259) 259
interferon (255) 255
hepacivirus - genetics (252) 252
asunaprevir (251) 251
genotype (234) 234
male (228) 228
hcv (218) 218
antiviral agents (215) 215
female (212) 212
drug therapy, combination (205) 205
middle aged (202) 202
hepacivirus - drug effects (188) 188
therapy (165) 165
ledipasvir (162) 162
health aspects (161) 161
cirrhosis (159) 159
treatment outcome (159) 159
daclatasvir plus sofosbuvir (155) 155
aged (153) 153
infection (151) 151
hepatitis c, chronic - virology (141) 141
pharmacology & pharmacy (139) 139
liver (138) 138
virus-infection (138) 138
adult (136) 136
infectious diseases (133) 133
sustained virological response (133) 133
patients (131) 131
virology (127) 127
antiviral agents - administration & dosage (126) 126
liver cirrhosis (124) 124
direct-acting antivirals (122) 122
simeprevir (118) 118
genotype 1 infection (117) 117
hepatitis c - drug therapy (117) 117
analysis (116) 116
antiviral agents - adverse effects (114) 114
care and treatment (114) 114
imidazoles - therapeutic use (112) 112
genetic aspects (110) 110
viruses (108) 108
drug therapy (106) 106
treatment-naive patients (103) 103
sustained virologic response (102) 102
genotypes (98) 98
infections (92) 92
biological response modifiers (91) 91
genotype & phenotype (89) 89
daclatasvir plus asunaprevir (88) 88
hepatology (87) 87
safety (87) 87
antiviral agents - pharmacology (83) 83
ribavirin - therapeutic use (83) 83
efficacy (82) 82
treatment-naive (82) 82
virus diseases (82) 82
liver transplantation (79) 79
hepatitis-c virus (78) 78
chronic hepatitis c (77) 77
hcv infection (77) 77
genotype 1 (76) 76
hepatitis c, chronic - complications (74) 74
medical research (74) 74
pegylated interferon (74) 74
telaprevir (74) 74
viral nonstructural proteins - antagonists & inhibitors (72) 72
sofosbuvir - therapeutic use (70) 70
treatment-experienced patients (70) 70
imidazoles - administration & dosage (69) 69
open-label (69) 69
combination (67) 67
protease inhibitors (67) 67
fibrosis (66) 66
medicine & public health (64) 64
microbiology (64) 64
medicine, experimental (63) 63
viral nonstructural proteins - genetics (63) 63
drug resistance, viral (62) 62
transplantation (62) 62
hepatitis c - virology (61) 61
sulfonamides - therapeutic use (59) 59
gastroenterology and hepatology (58) 58
ns5a inhibitor (58) 58
chronic infection (57) 57
ns5a (56) 56
antiviral therapy (54) 54
genotype 1b (52) 52
immunology (52) 52
research (52) 52
in-vitro (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (898) 898
Korean (57) 57
Japanese (11) 11
French (8) 8
German (8) 8
Hungarian (6) 6
Spanish (6) 6
Chinese (1) 1
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hepatology, ISSN 0270-9139, 01/2015, Volume 61, Issue 1, pp. 77 - 87
Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations in genotype prevalence. This poses a challenge to the improved... 
SEQUENCE-ANALYSIS | TRANSMISSION | SOFOSBUVIR | INFECTION | DACLATASVIR | RIBAVIRIN | GASTROENTEROLOGY & HEPATOLOGY | VIRAL-HEPATITIS | BURDEN | TREATMENT-NAIVE PATIENTS | EPIDEMIOLOGY | Prevalence | Internationality | Hepatitis C - epidemiology | Humans | Hepatitis C - virology | Hepacivirus - genetics | Genotype | Hepatitis | Genotype & phenotype | Genetic diversity | Index Medicus | Viral Hepatitis
Journal Article
Bioorganic and Medicinal Chemistry Letters, ISSN 0960-894X, 02/2013, Volume 23, Issue 3, pp. 779 - 784
In a recent disclosure, we described the discovery of dimeric, prolinamide-based NS5A replication complex inhibitors exhibiting excellent potency towards an... 
Daclatasvir | NS5A inhibitors | Stilbene replacement | Antivirals | HCV
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 03/2018, Volume 24, Issue 12, pp. 1361 - 1372
AIM To assess daclatasvir plus asunaprevir (DUAL) in treatment-naive patients from mainland China, Russia and South Korea with hepatitis C virus (HCV) genotype... 
Direct-acting antiviral | Liver disease | DACLATASVIR/ASUNAPREVIR | RIBAVIRIN | NS3 | Genotype 1b | Daclatasvir | Chronic hepatitis C | NS5A | Asunaprevir | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Index Medicus | Randomized Clinical Trial
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2019, Volume 63, Issue 4
HCV genotype 6 (GT-6) is found predominantly in East and Southeast Asia. Clinical studies have focused on patients infected with hepatitis C virus (HCV) GT-6a,... 
Resistance | Ombitasvir | NS5A | NS5B | HCV | Velpatasvir | Genotype 6 | Sofosbuvir | NS3 | Polymorphism | RECEIVING DACLATASVIR | INHIBITOR BMS-790052 | ombitasvir | velpatasvir | MICROBIOLOGY | polymorphism | RESISTANCE ANALYSIS | DACLATASVIR PLUS ASUNAPREVIR | RIBAVIRIN | resistance | sofosbuvir | NATURAL PREVALENCE | PHARMACOLOGY & PHARMACY | INFECTION | genotype 6
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 2019
Real-world data evaluating the effectiveness of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) treatment have been reported from different regions.... 
sofosbuvir | treatment | real-world evidence | hepatitis C | daclatasvir
Journal Article
Journal Article
Journal Article
Journal of Comparative Effectiveness Research, ISSN 2042-6305, 2018, Volume 7, Issue 8
To evaluate the cost-effectiveness of the novel all-oral direct-acting antiviral regimen daclatasvir + asunaprevir (DUAL), versus interferon-based regimens for... 
cost-effectiveness | daclatasvir + asunaprevir | hepatitis C
Journal Article